As of 2023, almost two thirds of all active pharmaceutical ingredients manufactured worldwide came from China and India. The concentration of critical products manufactured in only a few countries can lead to supply issues during times of crises, as seen during the COVID-19 pandemic.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
BioSpace. (September 5, 2024). Distribution of active pharmaceutical ingredient (API) production volume worldwide as of 2023, by region [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 15, 2026, from /statistics/1498065/api-production-volume-by-region/
BioSpace. "Distribution of active pharmaceutical ingredient (API) production volume worldwide as of 2023, by region." Chart. September 5, 2024. ÌÇÐÄÆÆ½â°æ. Accessed July 15, 2026. /statistics/1498065/api-production-volume-by-region/
BioSpace. (2024). Distribution of active pharmaceutical ingredient (API) production volume worldwide as of 2023, by region. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 15, 2026. /statistics/1498065/api-production-volume-by-region/
BioSpace. "Distribution of Active Pharmaceutical Ingredient (Api) Production Volume Worldwide as of 2023, by Region." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 5 Sep 2024, /statistics/1498065/api-production-volume-by-region/
BioSpace, Distribution of active pharmaceutical ingredient (API) production volume worldwide as of 2023, by region ÌÇÐÄÆÆ½â°æ, /statistics/1498065/api-production-volume-by-region/ (last visited July 15, 2026)
Distribution of active pharmaceutical ingredient (API) production volume worldwide as of 2023, by region [Graph], BioSpace, September 5, 2024. [Online]. Available: /statistics/1498065/api-production-volume-by-region/